The CSF concentration of Aβ is reduced while tau levels are elevated in AD patients (Apostolova et al., 2010; Toledo et al., 2013), and these typical CSF findings correlate with cerebral amyloid burden in PET (Masters and Selkoe, 2012; Scott et al., 2016). The gene discussed is MAPT; the disease is Alzheimer disease.